C Sadowsky

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Glucocorticoid medication, memory and steroid psychosis in medical illness
    O M Wolkowitz
    Department of Psychiatry, University of California Medical Center San Francisco 94143, USA
    Ann N Y Acad Sci 823:81-96. 1997
  2. ncbi Double-blind treatment of major depression with dehydroepiandrosterone
    O M Wolkowitz
    Department of Psychiatry, University of California Medical Center, San Francisco, USA
    Am J Psychiatry 156:646-9. 1999
  3. ncbi Treatment of depression with antiglucocorticoid drugs
    O M Wolkowitz
    Department of Psychiatry, University of California, San Francisco, School of Medicine 94143 0984, USA
    Psychosom Med 61:698-711. 1999
  4. ncbi Stress hormone-related psychopathology: pathophysiological and treatment implications
    O M Wolkowitz
    Department of Psychiatry, University of California, School of Medicine, San Francisco, USA
    World J Biol Psychiatry 2:115-43. 2001
  5. ncbi DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study
    O M Wolkowitz
    Department of Psychiatry, Center for Neurobiology and Psychiatry, University of California San Francisco UCSF School of Medicine, USA
    Neurology 60:1071-6. 2003
  6. ncbi The "steroid dementia syndrome": an unrecognized complication of glucocorticoid treatment
    Owen M Wolkowitz
    University of California, San Francisco, School of Medicine, 401 Parnassus Ave, Box F 0984, San Francisco, CA 94143 0984, USA
    Ann N Y Acad Sci 1032:191-4. 2004
  7. ncbi Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial
    Anton P Porsteinsson
    Alzheimer s Disease Care, Research and Education Program, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14620, USA
    Curr Alzheimer Res 5:83-9. 2008
  8. ncbi Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine
    F G Freitag
    Diamond Headache Clinic, Chicago, Ill 60614-1726, USA
    Headache 41:391-8. 2001
  9. ncbi Safety and efficacy of galantamine in subjects with mild cognitive impairment
    B Winblad
    Karolinska Institutet, Alzheimer s Disease Research Center, Division of Geriatric Medicine, Stockholm, Sweden
    Neurology 70:2024-35. 2008

Detail Information

Publications9

  1. ncbi Glucocorticoid medication, memory and steroid psychosis in medical illness
    O M Wolkowitz
    Department of Psychiatry, University of California Medical Center San Francisco 94143, USA
    Ann N Y Acad Sci 823:81-96. 1997
    ....
  2. ncbi Double-blind treatment of major depression with dehydroepiandrosterone
    O M Wolkowitz
    Department of Psychiatry, University of California Medical Center, San Francisco, USA
    Am J Psychiatry 156:646-9. 1999
    ..This study was designed to assess possible antidepressant effects of dehydroepiandrosterone (DHEA), an abundant adrenocortical hormone in humans...
  3. ncbi Treatment of depression with antiglucocorticoid drugs
    O M Wolkowitz
    Department of Psychiatry, University of California, San Francisco, School of Medicine 94143 0984, USA
    Psychosom Med 61:698-711. 1999
    ..The theoretical and empirical rationales for the potential therapeutic use of antiglucocorticoid agents in the treatment of depression are reviewed...
  4. ncbi Stress hormone-related psychopathology: pathophysiological and treatment implications
    O M Wolkowitz
    Department of Psychiatry, University of California, School of Medicine, San Francisco, USA
    World J Biol Psychiatry 2:115-43. 2001
    ..We then review certain clinical manifestations of such hormonal imbalances and discuss pharmacological and behavioural treatment strategies aimed at normalizing hormonal output and lessening psychiatric and physical pathology...
  5. ncbi DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study
    O M Wolkowitz
    Department of Psychiatry, Center for Neurobiology and Psychiatry, University of California San Francisco UCSF School of Medicine, USA
    Neurology 60:1071-6. 2003
    ..To compare the efficacy and tolerability of dehydroepiandrosterone (DHEA) vs placebo in AD...
  6. ncbi The "steroid dementia syndrome": an unrecognized complication of glucocorticoid treatment
    Owen M Wolkowitz
    University of California, San Francisco, School of Medicine, 401 Parnassus Ave, Box F 0984, San Francisco, CA 94143 0984, USA
    Ann N Y Acad Sci 1032:191-4. 2004
    ..Several clinical cases of this syndrome, with shared phenomenological and neuropsychological features, are presented here...
  7. ncbi Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial
    Anton P Porsteinsson
    Alzheimer s Disease Care, Research and Education Program, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14620, USA
    Curr Alzheimer Res 5:83-9. 2008
    ..To evaluate the efficacy and safety of memantine in patients with mild to moderate Alzheimer's disease (AD) receiving cholinesterase inhibitor (ChEI) treatment...
  8. ncbi Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine
    F G Freitag
    Diamond Headache Clinic, Chicago, Ill 60614-1726, USA
    Headache 41:391-8. 2001
    ..Several parameters suggest that isometheptene mucate, dichloralphenazone with acetaminophen may have a slight advantage compared with sumatriptan succinate in the early treatment of mild-to-moderate migraine...
  9. ncbi Safety and efficacy of galantamine in subjects with mild cognitive impairment
    B Winblad
    Karolinska Institutet, Alzheimer s Disease Research Center, Division of Geriatric Medicine, Stockholm, Sweden
    Neurology 70:2024-35. 2008
    ....